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A quantitative structure-activity relationship (QSAR) study has been made on 20 compounds with serotonin (5-HT) receptor
aﬃnity.Thin-layerchromatographic(TLC)dataandphysicochemicalparameterswereappliedinthisstudy.RP2TLC60F254 plates
(silanized)impregnatedwithsolutionsofpropionicacid,ethylbenzene,4-ethylphenol,andpropionamide(usedasanaloguesofthe
key receptor amino acids) and their mixtures (denoted as S1–S7 biochromatographic models) were used in two developing phases
as a model of drug-5-HT receptor interaction. The semiempirical method AM1 (HyperChem v. 7.0 program) and ACD/Labs v. 8.0
programwereemployedtocalculateasetofphysicochemicalparametersfortheinvestigatedcompounds.Correlationandmultiple
linear regression analysis were used to search for the best QSAR equations. The correlations obtained for the compounds studied
represent their interactions with the proposed biochromatographic models. The good multivariate relationships (R2 = 0.78–
0.84) obtained by means of regression analysis can be used for predicting the quantitative eﬀect of biological activity of diﬀerent
compounds with 5-HT receptor aﬃnity. “Leave-one-out” (LOO) and “leave-N-out” (LNO) cross-validation methods were used
to judge the predictive power of ﬁnal regression equations.
1.Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is a neurotrans-
mitter in the central nervous system (CNS) that plays a
signiﬁcant role in migraine attacks, mood regulation, sleep,
appetite, sexual function, anxiety treatment, depression, and
schizophrenia. This neurotransmitter interacts with fourteen
serotoninergic receptor subtypes, which are classiﬁed into
seven families (5-HT1−7). Until now, we can explain the
importance of functional groups 1–4; the physiological and
therapeutic importance of the group 5–7 receptors is not yet
known.Withtheexceptionof5-HT3 receptor,whichbelongs
to the family of ionotropic receptors, all are G protein-
coupled receptors (metabotropic receptors) [1].
Many models of ligand binding describe interaction of
ligands with serotonin receptors binding sites, but there
are diﬀerences in them even for the same subtype of 5-
HT receptor. Based on the available bibliographic data, it
is established that the essential role in the creation of drug-
serotonin receptor complex is played by the following amino
acids: aspartic acid (Asp155), serine (Ser159), phenylalanine
(Phe340), asparagine (Asn333), tryptophan (Trp200, 236,
367), tyrosine (Tyr370), and threonine (Thr196) [2–12]. A
detailed description of the model binding sites was presented
in earlier works [13, 14]. The information will make it
possible to build an analytical model of interaction ligands
with the 5-HT receptor and the initial prediction of potential
biological activity of its ligands.
Chromatographic systems including chemical elements
of the biological environment, simulating the conditions
under which the studied compounds would act in a living
organism (the so-called biochromatography) and thus the2 The Scientiﬁc World Journal
data obtained from such research (column, e.g., HPLC and
thin-layerchromatography,TLC),areusedveryfrequentlyin
quantitative structure-activity relationship (QSAR) studies
[15–24].QSARanalysisconsistsinamathematicaltreatment
that is used to predict values of biological activity from phys-
ical characteristics of the structure of chemicals (molecular
descriptors).
In the literature there are examples of biochromato-
graphic data analyses, their implications for molecular phar-
macology, and application in predicting pharmacological
activity of drugs [25–32]. In such studies are employed both
parameters obtained from the experimental interaction with
the environment (e.g., biochromatography) and calculated
physicochemicalparameters,whichresultfromtheconstruc-
tion of chemical compounds.
This paper is a continuation of the studies [13, 14],
whose purpose is to determine the possibility of using data
obtained from thin-layer chromatography and computer-
calculated physicochemical parameters to build regression
equations that will predict the receptor binding aﬃnity (pKi)
and agonist (pD2) and antagonistic (pA2) activity of selected
compounds acting on serotonin receptors. The choice of
model compounds for the binding elements in the receptor
structure was based on the literature data on the use of
propionicacidtomimicasparticacidstructureininteraction
with the ligands of the histamine H3 receptor [33, 34].
2. Experimental
2.1. Materials. Samples of the drugs 1–20 used in this work
were purchased either as medical products or as standard
substances [14] .A l lo ft h e mh a v eb i o l o g i c a la c t i v i t yt o w a r d
serotoninergic receptors, see Table 1. The active substances
wereisolatedfrommedicalproductswithmethodsdescribed
according to speciﬁc monographs presented in the Polish
Pharmacopoeia, and information is available in The Merck
Index [35]. Pharmacological details are given elsewhere [14].
Propionic acid, ethylbenzene, 4-ethylphenol, propi-
onamide, ethanol, isopropyl alcohol, and mobile-phase sol-
vents were purchased from the Sigma-Aldrich (Steinheim,
Germany).
2.2. Chromatography. Reversed-phase thin-layer chromatog-
raphy system (RP2 TLC) was used for determination of
the chromatographic data. The experiments were carried
out twice in each variant of the stationary and mobile
phase. TLC silica gel 60 RP2 F254 glass plates (silanized;
20 × 20cm, Merck, Darmstadt, Germany) were used as the
stationary phase. Chromatograms were developed in two
mobile phases, denoted as DSA and DSB: (i) acetonitrile:
methanol: buﬀer pH 7.4 (0.02mol/L ammonium acetate)
(40:40:20, v/v/v; DSA) and (ii) acetonitrile: methanol:
methylene chloride: buﬀer pH 7.4 (60:10:10:20, v/v/v/v;
DSB). All plates were ﬁrst prerun for 1.5h with the mobile
phase, dried at ambient temperature, and then impreg-
nated with 0.03mol/L analogues of binding L-amino acid
solutions ((a)–(g), see below) to obtain the corresponding
biochromatographic models. The models were denoted as
follows: (a) for propionic acid: S1, (b) ethylbenzene: S2, (c)
4-ethylphenol:S3,(d)propionamide:S4,(e)propionicacid+
ethanol(1:1, v/v): S5, (f) propionic acid + ethanol + ethyl-
benzene(1:1:1, v/v/v): S6, (g) propionamide + isopropyl
alcohol(1:1, v/v): S7.
The plates were impregnated with the solutions (a)–(g)
by spraying in automatic TLC spray chamber (ChromaJet
DS20, Desaga, Germany) and then air-dried. The impreg-
nated and dried adsorbent layers were ready for chromatog-
raphy. Additional plates (two for each type of mobile phase)
were left clean for control analysis (C), without analogues of
amino acids solutions.
The compounds 1–20 were weighed on analytical lab-
oratory scales with 0.1mg accuracy and then dissolved in
methanol to obtain 1.0mg/mL concentrations. The com-
pounds in 1.0μL quantities were applied onto the previously
prepared plates by means of Desaga AS30 TLC applicator
(Desaga, Germany), at 1.0cm intervals. The distance from
the lateral edges was 2cm. The start line was set at the
level of 1.5cm from the lower edge of the plate. The
chromatograms were developed in a horizontal chromato-
graphic chamber with an eluent dispenser, DS-II-20 × 20
(CHROMDES, Lublin, Poland) to the height of 12cm above
the lower edge of the plate. The duration of chromatograms
development was 35 ± 2min and 28± 2min (for eluents
DSA and DSB, resp.). The developed lanes were scanned
densitometrically at 280nm by means of a Desaga CD 60
densitometer with Windows-compatible ProQuant software
(Desaga, Germany). For the particular compounds, the
retention or retardation factor(Rf) values were read, and
then the RM values were calculated [36]: RM = log(1/Rf −1).
The RM values used for analysis constituted a mean from
two reproducible experiments. RM(S1)–RM(S7) and RM(C)
values for the analytes were presented in the course of the
described quantitative analysis as S1–S7 and C, respectively,
whereas the derivatives of these results were denoted with
symbols: C-S(1–7) and S(1–7)/C. Using parameters of C-
S(1–7) and S(1–7)/C has been justiﬁed in an earlier work
[14]. The results of chromatographic analysis are presented
in Table 2.
2.3. Calculation of the Molecular Descriptors. The semi-
empirical method AM1 with Polak-Ribi` ere algorithm
(HyperChem v. 7.0 program) [37] and ACD/Labs v. 8.0
program [38] were employed to calculate a set of physic-
ochemical parameters for the investigated compounds, see
Table 3. The following set of variables was collected using
(i)HyperChemprogram—thetotalenergy(ET,kcal ·mol−1),
the binding energy (Eb,k c a l ·mol−1), the heat of formation
(ΔHF,k c a l ·mol−1), the total dipole moment (μ, D), the
energy of the highest occupied molecular orbital (εHOMO,
eV), the energy of the lowest unoccupied molecular orbital
(εLUMO, eV), and the net atomic charge on the nitrogen
atom (QN), (ii) the module-QSAR Properties ChemPlus
2.1 included in Hyperchem software—the grid surface
area (AS, ˚ A2), the molar volume (Vm, ˚ A3), the hydration
energy (EH,k c a l ·mol−1), the logarithm of the octanol/water
partition coeﬃcient (log P), the molar refractivity (Rm,
˚ A3), polarizability (α, ˚ A3), and the molecular weight (MW,
g·mol−1), and (iii) ACD/Labs 8.0 program—the distributionThe Scientiﬁc World Journal 3
Table 1: Known biological activity for compounds 1–20.
No. Compound pKa
i pDb
2 pAc
2
1 Tiapride — 7.97 5.10
2 Clopenthixol 7.60 7.99 7.30
3 Flupentixol 7.00 7.88 6.90
4 Triﬂuoperazine 7.90 8.04 5.70
5 Clozapine 6.00 — 7.50
6 Risperidone 9.90 8.16 6.69
7 Olanzapine 8.10 8.10 7.20
8 Tropisetron 8.40 — 6.60
9 Cyproheptadine 8.22 — 8.73
10 Trazodone 7.40 — 8.79
11 Mianserin 9.70 8.09 7.50
12 Pizotifen 7.40 — 9.20
13 Mirtazapine 8.40 6.88 7.99
14 Buspirone 7.70 7.70 6.35
15 Sumatriptan 6.60 5.80 —
16 Rizatriptan 6.40 6.30 —
17 Zolmitriptan 6.60 6.20 —
18 Cisapride 7.40 7.60 7.30
19 Serotonin 6.40 — —
20 Propranolol 7.50 — 6.08
apKi: 5-HT receptor binding aﬃnity; bpD2: agonistic activity; cpA2: antagonistic activity.
Table 2: RM values for the experiment with RP2 TLC system.
RP2 TLC RM (DSA and DSB)
Compound RM(C)
(C)a
RM(S1)
(S1)b
RM(S2)
(S2)
RM(S3)
(S3)
RM(S4)
(S4)
RM(S5)
(S5)
RM(S6)
(S6)
RM(S7)
(S7)
Developing solvent DSA
1 −0.140 −0.167 −0.131 −0.176 −0.185 −0.176 −0.105 −0.140
2 0.026 0.026 0.140 0.043 0.078 0.087 0.105 0.087
3 0.043 0.043 0.131 0.043 0.087 0.078 0.096 0.096
4 0.308 0.308 0.389 0.298 0.317 0.308 0.368 0.327
5 −0.026 −0.035 0.035 0.000 0.009 −0.009 0.035 0.009
6 −0.259 −0.269 −0.231 −0.317 −0.269 −0.368 −0.250 −0.240
7 0.078 0.087 0.176 0.078 0.096 0.096 0.149 0.140
8 0.122 0.105 0.149 0.061 0.061 0.000 0.131 0.105
9 0.269 0.259 0.288 0.222 0.240 0.231 0.278 0.259
10 −0.466 −0.466 −0.410 −0.410 −0.389 −0.421 −0.389 −0.368
11 −0.035 −0.035 0.000 −0.035 −0.026 −0.009 0.000 0.017
12 0.269 0.278 0.308 0.250 0.231 0.222 0.288 0.327
13 −0.122 −0.122 −0.061 −0.122 −0.122 −0.087 −0.070 −0.070
14 −0.337 −0.337 −0.231 −0.337 −0.317 −0.317 −0.269 −0.269
15 −0.078 −0.140 −0.070 −0.176 −0.222 −0.158 −0.122 −0.140
16 0.194 0.203 0.399 0.213 0.140 0.259 0.240 0.231
17 −0.078 −0.096 0.017 −0.114 −0.167 −0.070 −0.035 −0.105
18 −0.240 −0.231 −0.105 −0.213 −0.222 −0.213 −0.185 −0.185
19 0.087 0.087 0.194 0.035 0.017 −0.026 0.140 0.087
20 0.105 0.105 0.176 0.078 0.043 0.026 0.114 0.0964 The Scientiﬁc World Journal
Table 2: Continued.
RP2 TLC RM (DSA and DSB)
Compound RM(C)
(C)a
RM(S1)
(S1)b
RM(S2)
(S2)
RM(S3)
(S3)
RM(S4)
(S4)
RM(S5)
(S5)
RM(S6)
(S6)
RM(S7)
(S7)
Developing solvent DSB
1 0.009 0.009 0.035 −0.035 −0.026 0.026 0.026 0.009
2 0.269 0.259 0.259 0.213 0.222 0.278 0.250 0.222
3 0.250 0.259 0.240 0.194 0.213 0.278 0.231 0.185
4 0.513 0.489 0.477 0.454 0.466 0.501 0.466 0.432
5 0.194 0.194 0.149 0.122 0.140 0.203 0.149 0.105
6 0.070 0.052 0.043 0.000 0.035 0.061 0.026 −0.017
7 0.327 0.368 0.347 0.259 0.288 0.288 0.308 0.259
8 0.131 0.096 0.131 0.070 0.114 0.087 0.131 0.096
9 0.410 0.378 0.389 0.317 0.358 0.410 0.368 0.347
10 −0.250 −0.250 −0.308 −0.389 −0.317 −0.231 −0.288 −0.368
11 0.203 0.194 0.185 0.122 0.158 0.122 0.158 0.105
12 0.489 0.432 0.149 0.368 0.347 0.466 0.389 0.378
13 0.149 0.149 0.131 0.078 0.096 0.158 0.114 0.078
14 −0.009 0.026 −0.043 −0.140 −0.087 0.009 −0.017 −0.017
15 −0.009 −0.035 −0.017 −0.070 −0.070 −0.026 −0.026 −0.078
16 0.278 0.308 0.317 0.240 0.231 0.298 0.278 0.240
17 0.017 0.000 0.043 −0.035 −0.026 0.035 0.026 −0.026
18 0.122 0.140 0.105 0.035 0.061 0.131 0.096 0.061
19 0.203 0.222 0.231 0.149 0.140 0.176 0.194 0.149
20 0.203 0.222 0.185 0.114 0.131 0.176 0.203 0.158
aRM(C): retention parameter of the compounds in control environment of chromatography; bRM(S1−S7): retention parameters of the compounds in S1–S7
models environment of chromatography.
coeﬃcient (log D), the polar surface area (PSA, ˚ A2), the
dissociation constant (pKa), the number of H-bond donors
(HD), and the number of H-bond acceptors (HA).
2.4. Statistical Analysis. Stepwise multiple linear regression
and correlation analysis were carried out using STATISTICA
9.0 program [39]. Values of biological activity (pKi,p D2 and
pA2) of the analyzed compounds were used as dependent
variables, as independent variables were applied in the
chromatographic data and the calculated physicochemical
descriptors.
The relationships between the behaviour of compounds
1–20 in chromatographic environments (C, S1–S7), their
physicochemical properties, and their biological activity gave
mathematical models whose statistical quality was estimated
using of the following statistical indicators: the correlation
coeﬃcient (R), the squared correlation coeﬃcient (the coef-
ﬁcient of determination, R2), the variance ratio F, and the
standard error of estimate (s), and the statistical signiﬁcance
(P-level) of the results was determined as P ≤ 0.05 (see
Table 4).
The correlation between the biological activities with
the various variables and the intercorrelation of descriptors
was analyzed with the help of the correlation matrix. If
two descriptors showed the correlation coeﬃcient |R| >
0.5, one of them would be removed. The respective inter-
correlation coeﬃcients between the parameters occurring
in the established regression models are given in Table 5.
Evaluation of the best correlation models was carried out
by validation of each model using general internal cross-
validation procedures such as the “leave-one-out” (LOO)
and “leave-N-out” (LNO). These kinds of internal validation
are recommended if the number of compounds is small
[40, 41]. The detailed procedures of these kinds of internal
validation were described in an earlier work [14].
The cross-validated squared correlation coeﬃcient (Q2),
predicted residual sum of squares (PRESS), standard devi-
ation based on PRESS (SPRESS), and standard deviation
of error of prediction (SDEP) were used to evaluate the
predictive power the developed models. Some criteria for
the reliability prediction and robustness of the models are
suggested by authors [42–46]: R2 > 0.6a n dQ2 > 0.5;
R2 ≥ Q2
LO(N)O and Q2
LOO ≈ Q2
LNO.
3. Results and Discussion
The present work is a continuation of the previous studies
[13, 14], whose purpose is to determine the possibility of
using data obtained from thin-layer chromatography and
computer-calculated physicochemical parameters to build
regression equations that will predict the receptor binding
aﬃnity(pKi)andagonist(pD2)andantagonistic(pA2)activ-
ityofselectedcompoundsactingonserotoninergicreceptors.
Similar studies have been carried out on compounds toward
β-adrenergic [47, 48] and histamine [49–52]r e c e p t o r s .The Scientiﬁc World Journal 5
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In this study, we took advantage of the data based on
the structure and function of serotoninergic receptors [12–
22]. On the basis of the information, was established that
the following amino acids: aspartic acid (Asp155), serine
(Ser159), phenylalanine (Phe340), asparagine (Asn333),
tyrosine (Tyr370), threonine (Thr196), and tryptophan
(Trp200, 236, 367), located within 5-HT receptors play the
most important role in ligands binding. This information
made it possible to think out a hypothetical model of drug-
serotonin receptor interaction, in which amino acids were
introduced into the stationary phase of chromatographic
environment [14].
The amino acids used to modify the stationary phase
in previous work [14] contain amine and carboxyl groups
which under biological conditions do not participate in
the formation of the active complex. They remain within
the protein structure forming peptide bonds. The presence
of these active groups in a chromatographic system might
lead to additional interactions with the compounds studied.
In further experiments with our models of interactions
with 5-HT receptors, we have thus used compounds (as
analogues of the key receptor amino acids) with structures
corresponding to those of crucial amino acids but without
the amine and carboxyl groups which form peptide bonds in
the receptor protein. And so for example, aspartic acid was
therefore replaced with propionic acid, phenylalanine with
ethylbenzene, tyrosine with 4-ethylphenol and asparagine
with propionamide. Application of ethanol and isopropyl
alcohol (as analogues of serine and threonine, resp.) as
the substances modifying the stationary phase individually
was devoid of sense. Ethanol and isopropyl alcohol were
used only in multicomponent solutions for impregnation
of plates. The choice of model compounds for the binding
elements in the receptor structure was based on the literature
data on the use of the propionic acid structure in studies
of the interaction of aspartic acid with the ligands of the
histamine H3 receptor [33, 34].
The correlation and the stepwise multiple linear regres-
sion analyses were carried out to answer the question
whether there is any relationship between the behaviour of
the compounds 1–20 in chromatographic environments S1–
S7 and their biological activity (pKi,p D2,a n dp A2).
First, we analysed the relationship between the biological
activity data and behaviour of the examined compounds
in chromatographic environment of the control (C: with-
out analogues of amino acids). The calculated correlation
coeﬃc i e n tv a l u e s( R) were (the regression equations are not
presentedinthetext)0.13and0.06(pKi,n = 19,forDSA and
DSB phases, resp.), 0.04 and 0.37 (pD2, n = 13, for DSA and
DSB phases, resp.), and 0.02 and 0.10 (pA2, n = 16, for DSA
andDSB phases,resp.).Asindicatedbytheanalysis,therewas
no correlation between serotoninergic activities of particular
compounds 1–20 and their C-chromatographic data. It led
to conclusions that the other signiﬁcant relationships can
depend upon the speciﬁc biochromatographic environment.
Distinct relationships between values of biological activity
and interactions data of the compounds 1–20 can be
observed with all the models (S1–S7) (see Table 4).
Under the conditions of experiment with DSA mobile
phase, distinct relationships were found for the compounds
with acknowledged binding aﬃnity pKi to the 5-HT receptor
((1), Table 4) and determined agonistic activity pD2 ((6),
Table 4). The binding aﬃnity pKi of the compounds to 5-
HT receptor was described on the basis of models S1, S2,
and S3. The relationship explains 68% of the variance and
simultaneously describes the potential interactions between
the ligands and amino acid residues: Asp155, Phe340, and
Tyr370. In the case of agonistic activity pD2,c h r o m a t o -
graphic models S4 and S5 demonstrate a signiﬁcant eﬀect
on regression equation, which explains 84% of the variance
and simultaneously describes the potential interactions
between the ligands and amino acid residues: Asn333,
Asp155, and Ser159. All types of interactions between the
structural elements of the receptor hydrophobic pocket and
the chemical substance in the drug-receptor complex are
represented in the above cases:ionic and hydrogen bonds, as
wellasstabilizationofaromaticligandsringsbyhydrophobic
forces. For compounds with antagonistic activity pA2, the
correlation was not statistically signiﬁcant (11).
In the case of DSB mobile phase and for compounds
with determined biological activity pKi (2) and pD2 (7),
the equations explain only 46–53% of total variance. The
satisfactoryresultsyieldedtheanalysisofcorrelationbetween
the data characterizing antagonistic activity pA2 and chro-
matographic parameters (R = 0.83; Equation (12)). The
relationship explains 69% of the total variance and describes
interactions of the ligands with amino acids: aspartic acid,
tyrosine, serine, and phenylalanine (S1, S3, and S6 models).
At the next stage of the study, in the multiple regression
analysis the molecular descriptors were employed as inde-
pendent variables (Table 3). The contribution of the same
descriptors in the development of regression equations was
describedinpreviouspapers[13,14].Theﬁnalmathematical
models for biological activity (pKi and pA2) explain 69% of
the total variance ((3) and (13)), and model for pD2 explains
only 57% of total variance (8).
Considering the role of molecular descriptors in predic-
tion of biological activity, these parameters were included
in the regression analysis together with chromatographic
data. The share of the calculated molecular descriptors in
the analysis of chromatographic models for DSA phase was
presented in the form of (4), (9), and (14). The satisfactory
result gave the regression analysis for compounds with pKi
and pA2 activity ((4) and (14)) where the mathematical
models explain 60–68% of the total variance. For the
dependent variable of pD2, the regression model explains
86% of the total variance, but the number of cases (n = 13)
doesnotqualifyfortheintroductionintoanalysisofthethree
independent variables.
Testing correlation for the development phase DSB
yielded good results of regression analysis for biological
activity pKi and pA2 ((5) and (15)). In both cases, the
mathematical models explain 80% of the total variance.
For compounds with agonistic activity pD2, the correlation
explains only 60% of the total variance ((17)-(18)). In
the above models, you can see the contribution of both
chromatographic data and the molecular descriptors.The Scientiﬁc World Journal 7
Table 4: Regression models for the correlation between values of biological activity (pKi, pD2, pA2) and chromatographic data and mol-
ecular descriptors.
Equation no. pKi Rc R2d Fe sf pg nh
(1)a a+b C - S 2− cS1/C + dS3/C − eS2/C 0.83 0.68 7.4815 0.6687 0.0019 19
(2)b a + bC-S5 − cS5/C − dC-S4 + eC-S1 0.73 0.53 4.0085 0.8087 0.0226 19
(3) a + bQN − cμ − dlogD 0.83 0.69 11.0470 0.6387 0.0004 19
(4)a a − bHD + clog P+d C - S 5+e Vm 0.78 0.60 5.3183 0.7462 0.0081 19
(5)b a − bHD + cC-S5 + dlog P − eC-S4 0.90 0.80 14.6095 0.5272 0.0001 19
pD2 =
(6)a a − bC-S4 + cC-S5 0.92 0.84 26.6280 0.3654 0.0001 13
(7)b a − bS5/C − cC-S4 0.68 0.46 4.2261 0.6766 0.0467 13
(8) a + blog D – cεLUMO 0.77 0.57 6.7003 0.6008 0.0142 13
(9)a a − bC-S4 + cC-S5 – dQN 0.93 0.86 19.2116 0.3560 0.0003 13
(10)b a+ b logD +c C −S4 0.77 0.60 7.4952 0.5814 0.0103 13
pA2 =
(11)a a −bC-S7+ cS1 + dS4/C 0.61 0.37 2.3231 1.0017 0.1267 16
(12)b a −bC-S6+cC-S3+dS1/C 0.83 0.69 8.8524 0.7026 0.0022 16
(13) a + b ΔHF− cμ +d Rm 0.83 0.69 8.8893 0.7073 0.0022 16
(14)a a −bμ −cS3/C − dC-S7 0.83 0.68 8.6594 0.7080 0.0025 16
(15)b a+b C - S 6+c ΔHF +dl o gP 0.88 0.78 14.0194 0.5934 0.0003 16
aChromatographic parameters from the experiment in RP2 TLC DSA system. bChromatographic parameters from the experiment in RP2 TLC DSB system.
cThe correlation coeﬃcient. dThe coeﬃcient of determination. eThe variance ratio F. fThe standard error of estimate. gThe signiﬁcance level of the equation.
hThe number of compounds used to derive the regression equation.
Table 5: QSAR statistics of signiﬁcant equations.
Equation
no. Equation R R2 R2
adj Fsp Q2
LOO SDEP PRESS SPRESS Q2
LNO n
(5)
pKi = 8.47(±0.33)−12.96(±4.99)HD +
19.98(±4.47)C-S5+0.43(±0.12)log P
−0.34(±0.12)C-S4
0.90 0.80 0.75 14.6095 0.5272 0.0001 0.70 0.5883 6.3052 0.5761 0.63 19
(6) pD2 =7.69(±0.11)−15.89(±2.18)C-S4 +
7.97(±2.36)C-S5 0.92 0.84 0.81 26.6280 0.3654 0.0001 0.73 0.4522 2.3390 0.4242 0.70 13
(15) pA2 = 6.49(±0.24) + 15.60(±6.74)C-S6 +
0.01(±0.001)ΔHF+0 . 4 5( ±0.17)log P 0.88 0.78 0.72 14.0194 0.5934 0.0003 0.57 0.7633 8.6092 0.7335 0.55 16
R2
adj: the adjusted squared correlation coeﬃcient; Q2
LOO and Q2
LNO: the squared correlation coeﬃcients of the LOO and LNO validation procedures,
respectively;SDEP:thestandarddeviationoferrorofprediction;PRESS:thepredictedresidualsumofsquares;SPRESS:thestandarddeviationbasedonPRESS.
It can be seen, in the case of these and previous
studies [13, 14], that combining chromatographic data with
physicochemical parameters has improved the results of
QSAR analysis. In (3)–(5), (8)–(10), and (13)–(15), we can
seeclearinﬂuenceofelectronic (thenet atomic chargeonthe
nitrogen atom, the total dipole moment, the energy of the
lowest unoccupied molecular orbital), thermodynamic (the
distribution coeﬃcient, the logarithm of the octanol/water
partition coeﬃcient, the molar volume, the heat of forma-
tion, and the molar refractivity), and structural (the number
of H-bond donors) descriptors as independent variables
determining biological activity.
As can be seen, QN,l o gP,a n dVm contribute positively
and μ,l o gD, and HD contribute negatively to 5-HT receptor
binding aﬃnity. Antagonistic activity has positive inﬂuence
on ΔHF, Rm, and log P and negative inﬂuence on μ.
Descriptor logD contributes positively to agonistic activity.
Moreover, in all equations, One notes the inﬂuence of
biochromatographic environments as the proposed models
of drug-receptor interaction.
On the basis of such analyses, mathematical equations
describing all the types of ligands interactions with 5-HT
receptors can be proposed: (5), (6), and (15). The models,
together with the statistical and validation parameters, are
given in Table 5.
Table 6 presents the correlation matrix, where it is shown
thattheselecteddescriptorsfromtheaboveequationsarenot
highly correlated. Table 7 and Figures 1, 2,a n d3 report the
comparison of observed and predicted values of biological
activity for (5), (6), and (15).8 The Scientiﬁc World Journal
Table 6: Correlation matrix of the biological activity (pKi, pA2,a n dpD2) and molecular descriptors used in (A) ((5) and (15)) and (B) (6).
C-S4 C-S5 C-S6 ΔHF log P HD pA2 pKi
(A)
C-S4 1.00
C-S5 −0.10 1.00
C-S6 0.62 0.08 1.00
ΔHF 0.10 0.22 0.34 1.00
log P 0.21 −0.20 0.02 −0.35 1.00
HD −0.12 −0.07 −0.46 −0.54 0.16 1.00
pA2 0.48 −0.10 0.62 0.60 0.23 −0.29 1.00
pKi −0.33 0.57 0.02 0.11 0.22 −0.39 −0.11 1.00
C-S4 C-S5 pD2
(B)
C-S4 1.00
C-S5 0.48 1.00
pD2 −0.81 −0.03 1.00
Table 7: Observed and predicted values of activity for Equations (5), (6), and (15).
Compound
pKi (5) pD2 (6) pA2 (5)
Observed Predicted Residual Observed Predicted Residual Observed Predicted Residual
1 — — — 7.97 7.26 0.71 5.10 4.78 0.32
2 7.60 7.30 0.30 7.99 8.04 −0.05 7.30 7.19 0.11
3 7.00 7.39 −0.39 7.88 8.11 −0.23 6.90 6.29 0.61
4 7.90 8.02 −0.12 8.04 7.85 0.19 5.70 6.64 −0.94
5 6.00 6.93 −0.93 — — — 7.50 7.53 −0.03
6 9.90 8.46 1.44 8.16 8.41 −0.25 6.69 7.43 −0.74
7 8.10 8.29 −0.19 8.10 7.83 0.27 7.20 7.34 −0.14
8 8.40 8.62 −0.22 — — — 6.60 6.23 0.37
9 8.22 8.55 −0.33 — — — 8.73 8.45 0.28
10 7.40 7.39 0.01 — — — 8.79 7.94 0.85
11 9.70 9.90 −0.20 8.09 7.62 0.47 7.50 8.12 −0.62
12 7.40 7.31 0.09 — — — 9.20 8.66 0.54
13 8.40 8.10 0.30 6.88 7.41 −0.53 7.99 8.10 −0.11
14 7.70 7.61 0.09 7.70 7.85 −0.15 6.35 6.93 −0.58
15 6.60 6.69 −0.09 5.80 6.05 −0.25 — — —
16 6.40 6.57 −0.17 6.30 6.31 −0.01 — — —
17 6.60 6.45 0.15 6.20 6.21 −0.01 — — —
18 7.40 7.45 −0.05 7.60 7.77 −0.17 7.30 6.86 0.44
19 6.40 5.89 0.51 — — — — — —
20 7.50 7.70 −0.20 — — — 6.08 6.43 −0.35
According to authors [45–49], terms for a reliable model:
Q2 > 0.5a n dR2 > 0.6, Q2
LOO ≤ R2 ≥ Q2
LNO and Q2
LOO ≈
Q2
LNO are fulﬁlled in the equations in Table 5. The relation
R2
adj <R 2 conﬁrms that models are not overparameterized.
These equations can be proposed as the tools for predic-
tion of 5-HT activity of novel compounds characterized by
various structures with 78–84% probability of obtaining a
reliable result.
On the basis of the results described, it is clearly apparent
that the simple analogues of amino acids important for
ligand–receptor interaction are useful for building analytical
models of the serotoninergic activity of drug candidates.
4. Conclusions
The QSAR models of compounds acting on serotoninergic
receptors have been developed based on chromatographic
data and electronic, thermodynamic, and structural descrip-
tors. In all the types of chromatographic systems described
above, models based on interaction of the compounds 1–20
with substances modifying the stationary phase have been
found regression. The chemicals (propionic acid, ethylben-
zene, 4-ethylphenol, and propionamide) used to impregnate
the plates can represent the interaction of the compounds
examined with the crucial amino acids (Asp, Phe, Tyr, andThe Scientiﬁc World Journal 9
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Figure 1: Observed versus predicted values of serotoninergic
binding aﬃnity pKi according to (5).
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Figure 2:ObservedversuspredictedvaluesofagonisticactivitypD2
according to (6).
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Figure 3: Observed versus predicted values of antagonistic activity
pA2 according to (15).
Asn, resp.). The proposed biochromatographic systems can
describe an interaction which is possible between the ligands
and the appropriate analogues of amino acids. A lack of
correlation between the activity of the compounds and their
behaviour in the control of chromatographic environment
conﬁrmed the important role of the presence of compounds
modifying the stationary phase of chromatographic systems
in construction of analytical drug-receptor interaction mod-
els. The predictive ability of models was demonstrated by
using “leave-one-out” and “leave-N-out” cross-validation
procedures. The results indicate that these models can be
successfully used to predict the activity of 5-HT receptor
ligands.
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